Chlorpheniramine maleate and Memory impairment - from FDA reports


Summary

Memory impairment is found among people who take Chlorpheniramine Maleate, especially for people who are male, 20-29 old , have been taking the drug for < 1 month, also take medication Temazepam, and have Crohn's disease . We study 3,020 people who have side effects while taking Chlorpheniramine maleate from FDA. Among them, 30 have Memory impairment. Find out below who they are, when they have Memory impairment and more.

What to expect?

If you take Chlorpheniramine maleate and have Memory impairment, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Chlorpheniramine maleate and have Memory impairment

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Chlorpheniramine Maleate

Chlorpheniramine maleate has active ingredients of chlorpheniramine maleate. It is often used in allergies. (latest outcomes from Chlorpheniramine maleate 3,338 users)

Memory Impairment

Memory impairment has been reported by people with multiple sclerosis, depression, pain, high blood pressure, high blood cholesterol (latest reports from 105,192 Memory impairment patients).

On Jan, 25, 2017

3,020 people reported to have side effects when taking Chlorpheniramine Maleate.
Among them, 30 people (0.99%) have Memory Impairment


Number of reports submitted per year:

Could Chlorpheniramine maleate cause Memory impairment?

Time on Chlorpheniramine Maleate when people have Memory Impairment *:

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Memory Impairment when taking Chlorpheniramine Maleate *:

  • female: 34.48 %
  • male: 65.52 %

Age of people who have Memory Impairment when taking Chlorpheniramine Maleate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 36.84 %
  • 30-39: 5.26 %
  • 40-49: 15.79 %
  • 50-59: 15.79 %
  • 60+: 26.32 %

Top conditions involved for these people *:

  • Headache (5 people, 16.67%)
  • Crohn's Disease (5 people, 16.67%)
  • Pain (3 people, 10.00%)
  • Ill-Defined Disorder (3 people, 10.00%)
  • Analgesic Therapy (3 people, 10.00%)

Top co-used drugs for these people *:

  • Temazepam (15 people, 50.00%)
  • Acetaminophen (12 people, 40.00%)
  • Omeprazole (11 people, 36.67%)
  • Ibuprofen (11 people, 36.67%)
  • Levothyroxine Sodium (10 people, 33.33%)

Top other side effects for these people *:

  • Stress And Anxiety (20 people, 66.67%)
  • Breathing Difficulty (19 people, 63.33%)
  • Headache (15 people, 50.00%)
  • Hypersensitivity (14 people, 46.67%)
  • Dizziness (12 people, 40.00%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Memory impairment when taking Chlorpheniramine maleate?

Browse all side effects of Chlorpheniramine maleate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Memory impairment

Memory impairment

Could your condition cause Memory impairment

Memory impairment

Related studies

Can you answer these questions?

More questions for: Chlorpheniramine maleate, Memory impairment

You may be interested in these reviews

More reviews for: Chlorpheniramine maleate, Memory impairment